The Cancer Section of Imperial Clinical Trials Unit (ICTU-Ca) is based at Imperial College’s Hammersmith Campus.  Led by Professor Michael Seckl, Imperial AHSC Cancer Clinical Trials Lead, the cancer team supports trials in all phases of drug development across multiple sites of disease (breast, gastrointestinal, gynaecological and brain).  The cancer portfolio exploits the research expertise in the Division of Cancer to enable trials that include new and exciting imaging modalities, translational research initiatives and innovative study designs as they evolve

For further information regarding our services and how we can collaborate, please contact our team